Invesco’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Invesco’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-219	Closed	-$31K	–	4208
2022 Q1	$31K	Sell	219 -5	-2%	-$730	﹤0.01%	3965
2021 Q4	$38K	Sell	224 -150	-40%	-$55.9K	﹤0.01%	4000
2021 Q3	$187K	Buy	374 +96	+35%	+$44.5K	﹤0.01%	3826
2021 Q2	$139K	Buy	+278	New	+$149K	﹤0.01%	3847
2019 Q1	–	Sell	-123	Closed	-$15K	–	3871
2018 Q4	$15K	Buy	123 +1	+0.8%	+$153	﹤0.01%	3770
2018 Q3	$19K	Buy	122 +28	+30%	+$11.7K	﹤0.01%	3849
2018 Q2	$62K	Buy	+94	New	+$70.3K	﹤0.01%	3797
2015 Q2	–	Sell	-609	Closed	-$1.38M	–	4385
2015 Q1	$1.38M	Buy	+609	New	+$1.04M	﹤0.01%	2857

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's AMPE Position: Q2 2022 in Review

Invesco sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 219 shares — an estimated $31K sold.

Invesco first reported a position in AMPE in Q1 2015 and held it in 8 quarters. The position peaked at $1.38M in Q1 2015. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

Invesco reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
Invesco sold 219 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $31K.
Invesco first reported a position in Ampio Pharmaceuticals Inc. in Q1 2015 and held it in 8 quarters.
Invesco's Ampio Pharmaceuticals Inc. position peaked at $1.38M in Q1 2015.
111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.